These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The association of race, ethnicity, and socioeconomic status on the severity of menopause symptoms: a study of 68,864 women. Kochersberger A; Coakley A; Millheiser L; Morris JR; Manneh C; Jackson A; Garrison JL; Hariton E Menopause; 2024 Jun; 31(6):476-483. PubMed ID: 38652870 [TBL] [Abstract][Full Text] [Related]
6. Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN). Reeves AN; Lewis TT; Hood MM; Thurston RC; Avis NE; Burnett-Bowie SM; Cortés YI; Neal-Perry G; Harlow SD Menopause; 2024 Jun; 31(6):484-493. PubMed ID: 38595299 [TBL] [Abstract][Full Text] [Related]
7. Beyond frequency: who is most bothered by vasomotor symptoms? Thurston RC; Bromberger JT; Joffe H; Avis NE; Hess R; Crandall CJ; Chang Y; Green R; Matthews KA Menopause; 2008; 15(5):841-7. PubMed ID: 18521049 [TBL] [Abstract][Full Text] [Related]
8. Phytoestrogens for menopausal vasomotor symptoms. Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914 [TBL] [Abstract][Full Text] [Related]
9. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Avis NE; Stellato R; Crawford S; Bromberger J; Ganz P; Cain V; Kagawa-Singer M Soc Sci Med; 2001 Feb; 52(3):345-56. PubMed ID: 11330770 [TBL] [Abstract][Full Text] [Related]
10. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency. Jenks BH; Iwashita S; Nakagawa Y; Ragland K; Lee J; Carson WH; Ueno T; Uchiyama S J Womens Health (Larchmt); 2012 Jun; 21(6):674-82. PubMed ID: 22409590 [TBL] [Abstract][Full Text] [Related]
11. Monthly variation of hot flashes, night sweats, and trouble sleeping: effect of season and proximity to the final menstrual period (FMP) in the SWAN Menstrual Calendar substudy. Harlow SD; Elliott MR; Bondarenko I; Thurston RC; Jackson EA Menopause; 2020 Jan; 27(1):5-13. PubMed ID: 31567864 [TBL] [Abstract][Full Text] [Related]
12. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Sievert LL; Morrison L; Brown DE; Reza AM Menopause; 2007; 14(2):261-9. PubMed ID: 17151510 [TBL] [Abstract][Full Text] [Related]
13. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771 [TBL] [Abstract][Full Text] [Related]
14. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. St Germain A; Peterson CT; Robinson JG; Alekel DL Menopause; 2001; 8(1):17-26. PubMed ID: 11201510 [TBL] [Abstract][Full Text] [Related]
15. Natural history of menopause symptoms in primary care patients: a MetroNet study. Xu J; Bartoces M; Neale AV; Dailey RK; Northrup J; Schwartz KL J Am Board Fam Pract; 2005; 18(5):374-82. PubMed ID: 16148247 [TBL] [Abstract][Full Text] [Related]
16. Negative affect and vasomotor symptoms in the Study of Women's Health Across the Nation Daily Hormone Study. Gibson CJ; Thurston RC; Bromberger JT; Kamarck T; Matthews KA Menopause; 2011 Dec; 18(12):1270-7. PubMed ID: 21900850 [TBL] [Abstract][Full Text] [Related]
17. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. Zhu D; Chung HF; Dobson AJ; Pandeya N; Anderson DJ; Kuh D; Hardy R; Brunner EJ; Avis NE; Gold EB; El Khoudary SR; Crawford SL; Mishra GD Am J Obstet Gynecol; 2020 Dec; 223(6):898.e1-898.e16. PubMed ID: 32585222 [TBL] [Abstract][Full Text] [Related]
18. Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms. Abdi F; Kazemi F; Ramezani Tehrani F; Roozbeh N BMJ Open; 2016 Apr; 6(4):e010734. PubMed ID: 27105715 [TBL] [Abstract][Full Text] [Related]
19. Impact of nulliparity, hypertensive disorders of pregnancy, and gestational diabetes on vasomotor symptoms in midlife women. Cortés YI; Conant R; Catov JM; Matthews KA; Crawford SL; Hedderson MM; Thurston RC Menopause; 2020 Dec; 27(12):1363-1370. PubMed ID: 32796290 [TBL] [Abstract][Full Text] [Related]
20. Symptom experience of Filipino American midlife women. Berg JA; Taylor DL Menopause; 1999; 6(2):105-14. PubMed ID: 10374216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]